I hadn't heard that. That's a good sign. My hope is that we can enroll the first 50 patients in the severe trial very quickly. I did read that the FDA will do an interim review once the 50 hit 2 weeks.

My hope is that they will decide to look at the data after 1 week if promising. If we are able to enroll 50 in the next week, we could get them to look at it in 2 weeks. but I realize this is very optomistic.